Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_239.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_240.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | albo-ex231_241.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | albo-ex211_242.htm |
| EX-10.15 - EX-10.15 - ALBIREO PHARMA, INC. | albo-ex1015_447.htm |
| EX-10.14 - EX-10.14 - ALBIREO PHARMA, INC. | albo-ex1014_444.htm |
| EX-10.13 - EX-10.13 - ALBIREO PHARMA, INC. | albo-ex1013_443.htm |
| EX-10.10.4 - EX-10.10.4 - ALBIREO PHARMA, INC. | albo-ex10104_441.htm |
| EX-10.9.3 - EX-10.9.3 - ALBIREO PHARMA, INC. | albo-ex1093_442.htm |
| EX-10.7 - EX-10.7 - ALBIREO PHARMA, INC. | albo-ex107_440.htm |
| EX-4.1 - EX-4.1 - ALBIREO PHARMA, INC. | albo-ex41_445.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-10k_20160930.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended September 30, 2016 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: December 22, 2016 |
|
/s/ Ronald H.W. Cooper |
|
|
|
Ronald H.W. Cooper |
|
|
|
President and Chief Executive Officer (principal executive officer) |
|
Dated: December 22, 2016 |
|
/s/ Thomas A. Shea |
|
|
|
Thomas A. Shea |
|
|
|
Chief Financial Officer (principal financial officer and principal accounting officer) |